Skip to main navigation Skip to search Skip to main content

Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors

  • Joshua D. Bernstock
  • , Asim K. Bag
  • , John Fiveash
  • , Kara Kachurak
  • , Galal Elsayed
  • , Gustavo Chagoya
  • , Florian Gessler
  • , Pablo A. Valdes
  • , Avi Madan-Swain
  • , Richard Whitley
  • , James M. Markert
  • , G. Yancey Gillespie
  • , James M. Johnston
  • , Gregory K. Friedman

Research output: Contribution to journal › Article › peer-review

31   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science